Enlivex Therapeutics Ltd (ENLV) — Tangible Net Worth Ratio
Enlivex Therapeutics Ltd (ENLV) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets (ILA0.00) from net assets (ILA17.48 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ENLV net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Enlivex Therapeutics Ltd Tangible Net Worth Ratio (2012–2024)
This chart shows how Enlivex Therapeutics Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of ILA17.48 Million with intangible assets of ILA0.00 ILA. Also explore Enlivex Therapeutics Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Enlivex Therapeutics Ltd (2012–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Enlivex Therapeutics Ltd stock valuation.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | ILA23.59 Million | ILA0.00 | ILA27.69 Million | ▲ +0.0 pp |
| 2023 | 100.0% | ILA30.08 Million | ILA0.00 | ILA36.83 Million | ▲ +0.0 pp |
| 2022 | 100.0% | ILA56.84 Million | ILA0.00 | ILA67.64 Million | ▲ +0.0 pp |
| 2021 | 100.0% | ILA85.04 Million | ILA0.00 | ILA95.15 Million | ▲ +0.0 pp |
| 2020 | 100.0% | ILA35.49 Million | ILA0.00 | ILA40.36 Million | ▲ +3.6 pp |
| 2019 | 96.4% | ILA11.28 Million | ILA410.00K | ILA17.56 Million | ▼ -3.6 pp |
| 2018 | 100.0% | ILA9.71 Million | ILA0.00 | ILA11.03 Million | ▲ +0.0 pp |
| 2017 | 100.0% | ILA3.16 Million | ILA0.00 | ILA3.62 Million | ▲ +0.0 pp |
| 2016 | 100.0% | ILA8.70 Million | ILA0.00 | ILA10.63 Million | ▲ +0.0 pp |
| 2015 | 100.0% | ILA17.93 Million | ILA0.00 | ILA20.52 Million | ▲ +0.0 pp |
| 2014 | 100.0% | ILA30.67 Million | ILA0.00 | ILA32.95 Million | ▲ +0.0 pp |
| 2013 | 100.0% | ILA5.55 Million | ILA0.00 | ILA5.69 Million | ▲ +0.0 pp |
| 2012 | 100.0% | ILA75.00K | ILA0.00 | ILA156.00K | — |